Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.sciencedirect.com › science › articleImpact of Anatomical and Viability-guided Completeness of ...

    Hace 6 días · Anatomical and viability-guided completeness of revascularization were measured by the coronary and myocardial revascularization indices (RI coro and RI myo) respectively, where RI coro =[change in BCIS Jeopardy Score (BCIS-JS)] / [baseline BCIS-JS] and RI myo =[number of revascularized viable segments] / [ number of viable segments ...

  2. www.ahajournals.org › doi › abs2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of...

    8 de may. de 2024 · Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

  3. www.jacc.org › doi › 102024 Hypertrophic Cardiomyopathy Guideline-at-a-Glance

    8 de may. de 2024 · High-intensity exercise and competitive sport may be considered in asymptomatic low-risk individuals with morphologically mild hypertrophic cardiomyopathy in the absence of resting or inducible left ventricular outflow obstruction and exercise-induced complex ventricular arrhythmias (COR 2b).

  4. www.nejm.org › doi › fullAficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy...

    13 de may. de 2024 · One of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from...

  5. www.acc.org › 2024/05/06 › 15/12/2024-hypertrophic-cardiomyopathy-gl2024 AHA/ACC/Multisociety Hypertrophic Cardiomyopathy Guideline:...

    8 de may. de 2024 · In HCM patients with clinical AF or subclinical AF of >24 hours’ duration, irrespective of CHA 2 DS 2-VASc score, systemic anticoagulation is recommended with a direct-acting oral anticoagulant (DOAC) as first line and vitamin K antagonist as second line.

  6. www.intechopen.com › online-first › 1180971Understanding Cardiomyopathy: Epidemiology, Risk Factors, Types...

    6 de may. de 2024 · This review provides a thorough understanding of cardiomyopathy, covering a wide range of crucial aspects, including epidemiology, risk factors, types, subcellular and molecular mechanisms, clinical presentation, diagnostic approaches, treatment modalities, and prevention strategies, a profound understanding of these aspects is ...

  7. journals.plos.org › plosntds › articleMortality risk score for patients with Chagas cardiomyopathy and...

    9 de may. de 2024 · The score identified patients with: low (0–20 points), interme-diate (21–30 points) and high risk (>31points). The optimism-corrected C-statistic of the predictive model was 0.751 (95% CI 0.696– 0.806).